We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Attention to CAPA Process Worth Effort, FDA Says
Attention to CAPA Process Worth Effort, FDA Says
November 7, 2008
Closing a corrective and preventive action (CAPA) and opening a new one after the original action failed its effectiveness check may give the appearance of malfeasance, according to an FDA investigator.